<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVETo 1) determine if plasma 25-hydroxyvitamin D (25[OH]D) concentrations differ among <z:mp ids='MP_0001261'>obese</z:mp> youth with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) versus <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> versus type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and 2) assess the relationships between 25(OH)D and in vivo insulin sensitivity and β-cell function in this cohort.RESEARCH DESIGN AND METHODSPlasma 25(OH)D concentrations were examined in banked specimens in 9- to 20-year-old <z:mp ids='MP_0001261'>obese</z:mp> youth (n = 175; male 42.3%, black 46.3%) (NGT, n = 105; <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> [IGT], n = 43; type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, n = 27) who had in vivo insulin sensitivity and secretion measured by hyperinsulinemic-euglycemic and hyperglycemic clamp techniques and had an assessment of total body composition and abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>.RESULTSThe mean age and BMI of the subjects were 14.3 ± 2.1 years and 35.7 ± 5.6 kg/m(2), respectively </plain></SENT>
<SENT sid="1" pm="."><plain>BMI, plasma 25(OH)D, and the proportion of <z:chebi fb="27" ids="27300">vitamin D</z:chebi>-deficient and -insufficient children did not differ across the three groups </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, there was no association between 25(OH)D and in vivo insulin sensitivity or β-cell function relative to insulin sensitivity (disposition index) in <z:hpo ids='HP_0000001'>all</z:hpo> groups combined or in each group separately.CONCLUSIONSOur data in <z:mp ids='MP_0001261'>obese</z:mp> youth show 1) no differences in plasma 25(OH)D concentrations across the <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance groups, and 2) no relationship between 25(OH)D and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in any of the groups </plain></SENT>
<SENT sid="3" pm="."><plain>It remains uncertain if enhancement of the <z:chebi fb="27" ids="27300">vitamin D</z:chebi> status could improve pathophysiological mechanisms of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0001261'>obese</z:mp> youth </plain></SENT>
</text></document>